Kat2b-KO 基因敲除小鼠

1. Ghasemi, Alaleh, Farazmand, Ali, Hassanzadeh, Vahideh, Jamshidi, Ahmadreza, Mahmoudi, Mahdi. 2022. Upregulation of KAT2B and ESCO2 gene expression level in patients with rheumatoid arthritis. In Clinical rheumatology, 42, 253-259. doi:10.1007/s10067-022-06351-4. https://pubmed.ncbi.nlm.nih.gov/36104638/

2. Hou, Yong-Sheng, Wang, Jing-Zhi, Shi, Shuai, Wang, Gui-Yu, Liu, Shu-Lin. . Identification of epigenetic factor KAT2B gene variants for possible roles in congenital heart diseases. In Bioscience reports, 40, . doi:10.1042/BSR20191779. https://pubmed.ncbi.nlm.nih.gov/32239175/

3. Zhou, Xue, Wang, Ning, Zhang, Yuefeng, Yu, Hongzhi, Wu, Qi. 2021. KAT2B is an immune infiltration-associated biomarker predicting prognosis and response to immunotherapy in non-small cell lung cancer. In Investigational new drugs, 40, 43-57. doi:10.1007/s10637-021-01159-6. https://pubmed.ncbi.nlm.nih.gov/34499335/

4. Gonçalves, Sara, Patat, Julie, Guida, Maria Clara, Antignac, Corinne, Simons, Matias. 2018. A homozygous KAT2B variant modulates the clinical phenotype of ADD3 deficiency in humans and flies. In PLoS genetics, 14, e1007386. doi:10.1371/journal.pgen.1007386. https://pubmed.ncbi.nlm.nih.gov/29768408/